2012 US Hemostasis Diagnostics Market Outlook: Growth Opportunities and Strategies


April 20, 2012
424 Pages - SKU: VPG3867696
License type:
Table of Contents Related Reports
Bioinformatics in IVD Testing
6/7/2013 | published by: Kalorama Information
Computer diagnostics could offer opportunity for clinical laboratory professionals to add value to clinicians in diagnosing diseases. IT companies in collaboration with test vendors are developing computer software that complements the skills of  |  read more...
$1,995.00
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
5/23/2013 | published by: Kalorama Information
The global blood industry has experienced strong growth in recent years and although this brisk expansion will slow somewhat as products continue to mature and pricing pressures increase, growth will remain solid though  |  read more...
$3,500.00
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,  |  read more...
$4,500.00
Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU)
5/29/2013 | published by: Venture Planning Group
This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth,  |  read more...
$12,500.00
2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices
6/7/2013 | published by: Venture Planning Group
This new 262-page report from Venture Planning Group provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The  |  read more...
$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices
6/4/2013 | published by: Venture Planning Group
This new 249-page report from Venture Planning Group provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report  |  read more...
$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs
6/4/2013 | published by: Venture Planning Group
This new 247-page report from Venture Planning Group provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report  |  read more...
$2,450.00
Global Electro-Diagnostic Equipment Market to 2017 - Market Size, Growth, and Forecasts in Nearly 70 Countries
6/1/2013 | published by: MarketSizeInfo.com
Global Electro-Diagnostic Equipment Market to 2017 - Market Size, Growth and Forecasts in Nearly 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for  |  read more...
$2,570.00
Competing in the US Point-of-Care Diagnostic Testing Market
5/29/2013 | published by: Venture Planning Group
This new 1,172-page report from Venture Planning Group contains 256 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and  |  read more...
$16,500.00
Analysis of the Respiratory Disease Testing Market in Europe: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
6/14/2013 | published by: Venture Planning Group
This new 335-page report from Venture Planning Group, Analysis of the Respiratory Disease Testing Market in Europe: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis , provides analysis of the European respiratory disease testing market, including  |  read more...
$8,300.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Diagnostics Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!